Title:
HYDROXAMIC ACID COMPOUND HAVING ENPP1 INHIBITORY ACTIVITY AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2023/036289
Kind Code:
A1
Abstract:
Disclosed are a compound of formula (I) having ENPP1 inhibitory activity, a pharmaceutical composition thereof and use thereof. The compound of formula (I) can be used for preventing or treating the diseases or disorders mediated by the ENPP1 abnormal activity.
More Like This:
Inventors:
GAO SHANYUN (CN)
LI JINGJING (CN)
ZHANG CHAOBO (CN)
XU YANXIAO (CN)
TU WANGYANG (CN)
YU BING (CN)
ZHANG YIXIANG (CN)
LI LEPING (CN)
LI JINGJING (CN)
ZHANG CHAOBO (CN)
XU YANXIAO (CN)
TU WANGYANG (CN)
YU BING (CN)
ZHANG YIXIANG (CN)
LI LEPING (CN)
Application Number:
PCT/CN2022/118080
Publication Date:
March 16, 2023
Filing Date:
September 09, 2022
Export Citation:
Assignee:
HAIHE BIOPHARMA CO LTD (CN)
International Classes:
C07D239/94; A61K31/47; A61K31/517; A61K31/519; A61P31/04; A61P31/12; A61P35/00; C07D215/233; C07D215/36; C07D215/38; C07D239/88; C07D239/93; C07D471/04
Domestic Patent References:
WO2020160333A1 | 2020-08-06 | |||
WO2019046778A1 | 2019-03-07 | |||
WO2020008391A1 | 2020-01-09 | |||
WO2020058290A1 | 2020-03-26 | |||
WO2019046778A1 | 2019-03-07 |
Foreign References:
CN107513064A | 2017-12-26 | |||
CN112390781A | 2021-02-23 |
Other References:
LI, SHUNDA ET AL.: "Development of selective HDAC6 inhibitors with in vitro and in vivo anti-multiple myeloma activity", BIOORGANIC CHEMISTRY, vol. 116, 19 August 2021 (2021-08-19), XP086829615, ISSN: 0045-2068, DOI: 10.1016/j.bioorg.2021.105278
ZENG, HUIJU ET AL.: "Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 192, 29 February 2020 (2020-02-29), XP086102471, ISSN: 0223-5234, DOI: 10.1016/j.ejmech.2020.112193
"Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING COMPANY, pages: 1289 - 1329
"Remington: The Science and Practice of Pharmacy", 1995, MACK PUBLISHING COMPANY
CELL CHEMICAL BIOLOGY, no. 27, 2020, pages 1347 - 1358
ZENG, HUIJU ET AL.: "Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer's disease", EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, vol. 192, 29 February 2020 (2020-02-29), XP086102471, ISSN: 0223-5234, DOI: 10.1016/j.ejmech.2020.112193
"Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING COMPANY, pages: 1289 - 1329
"Remington: The Science and Practice of Pharmacy", 1995, MACK PUBLISHING COMPANY
CELL CHEMICAL BIOLOGY, no. 27, 2020, pages 1347 - 1358
Attorney, Agent or Firm:
ZHONGZI LAW OFFICE (CN)
Download PDF:
Previous Patent: FLEXIBLE PHOTOVOLTAIC CELL ASSEMBLY AND MANUFACTURING METHOD THEREFOR
Next Patent: HEATING DEVICE AND METHOD FOR VEHICLE-MOUNTED CUP
Next Patent: HEATING DEVICE AND METHOD FOR VEHICLE-MOUNTED CUP